JNJ logo

Johnson & Johnson

JNJ
Healthcare|Drug Manufacturers - General|US
$276.22
+3.90 (+1.43%)
DCF Value
$295.64
Graham Number
$70.20
Cash / Share
$7.04
Next Earnings Report
Jan 26, 2027
EPS est. $2.91 · Revenue est. $26.42B
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Feb 11, 2026 (S-3ASR). Possible dilution.

Upcoming Data Readouts (17)

Nov 2026
Est. completion
NABreast Cancer (Locally Advanced or Metastatic)
Remote Monitoring and Symptom Management Digital Application
Dec 2026
Est. completion
Dysphotopsia
Clinical Evaluation of Low Contrast Visual Performance and Low Light Phenomena in Patients With Various Intraocular Lens Implants
Dec 2026
Est. completion
NALiver Disease Chronic
LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
Dec 2026
Est. completion
NAVisual Acuity
Evaluation of Approved Contact Lenses (CR-6657)
Dec 2026
Est. completion
NAAnkle Fractures
Fibulink Syndesmosis Repair System With Early Full-Weight Bearing
Feb 2027
Est. completion
P4Multiple Myeloma
A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma
Aug 2027
Est. completion
NAJuxtarenal Abdominal Aortic Aneurysm
University of Utah PS-IDE: Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysms
Aug 2027
Est. completion
NAHip Osteoarthritis
Emphasys Radiostereometric Analysis
Feb 2028
Est. completion
Intracranial Aneurysm
A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial Aneurysms
Jul 2028
Est. completion
Atrial Fibrillation
A Study of Varipulse Catheter in Participants With Paroxysmal Atrial Fibrillation Under Optimized Sedation
Oct 2028
Est. completion
Cardiogenic Shock Post Myocardial Infarction
Rapid Microaxial Flow Pump Support and Escalation in Patients With Myocardial Infarction Associated Cardiogenic Shock and Persistent Need of Hemodynamic Support
Dec 2028
Est. completion
NAHeart Failure
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
Aug 2029
Est. completion
P2Multiple Myeloma
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
Aug 2029
Est. completion
Colorectal Cancer Screening
Positive Fit to Colonoscopy: Closing the Gap
Apr 2030
Est. completion
NAAnkle Arthritis
Canadian Orthopaedic Foot and Ankle Society Surgical Treatment of Ankle Arthritis Outcome Study
Oct 2030
Est. completion
P1P2Plasma Cell Disorder
Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders
Jun 2031
Est. completion
NAOsteoarthritis, Hip
Clinical Outcomes of Primary Cementless Total Hip Arthroplasty Using the Collarless Actis Stem

Awaiting Results (4)

Trials past primary completion date but still active — data readout may be imminent.

Mar 2026
NA
Remote MS Care in Antwerp
NCT06179758
Nov 2025
NA
A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors
NCT06153797
Dec 2024
NA
Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Congenital Diaphragm Hernia
NCT02596802
Dec 2012
NA
The Nordic-Baltic Bifurcation Study IV
NCT01496638

Recent Press Releases

SEC Filings (73)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 26, 202613F-HRInstitutional holdings reportDocumentIndex
Oct 21, 202610-QQuarterly reportDocumentIndex
Oct 13, 20268-KMaterial eventDocumentIndex
Aug 11, 2026N-PXDocumentIndex
Aug 6, 202613F-HRInstitutional holdings reportDocumentIndex
Aug 4, 20268-KMaterial eventDocumentIndex
Jul 29, 20268-KMaterial eventDocumentIndex
Jul 28, 20268-KMaterial eventDocumentIndex
Jul 23, 202610-QQuarterly reportDocumentIndex
Jul 15, 20268-KMaterial eventDocumentIndex
Jun 25, 202611-KDocumentIndex
Jun 25, 202611-KDocumentIndex
May 27, 2026SDDocumentIndex
May 13, 202613F-HRInstitutional holdings reportDocumentIndex
May 1, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 28, 20268-KMaterial eventDocumentIndex
Apr 22, 202610-QQuarterly reportDocumentIndex
Apr 14, 20268-KMaterial eventDocumentIndex
Apr 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 26, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 18, 202613F-HR/AInstitutional holdings reportDocumentIndex
Mar 18, 202613F-HR/AInstitutional holdings reportDocumentIndex
Mar 11, 2026ARSAnnual report to holdersDocumentIndex
Mar 11, 2026DEFA14AProxy / shareholder voteDocumentIndex
Mar 11, 2026DEF 14AProxy / shareholder voteDocumentIndex
Feb 13, 202613F-HRInstitutional holdings reportDocumentIndex
Feb 11, 2026S-3ASRShelf registrationDocumentIndex
Feb 11, 202610-KAnnual reportDocumentIndex
Feb 5, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 21, 20268-KMaterial eventDocumentIndex
Jan 12, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Nov 13, 202513F-HRInstitutional holdings reportDocumentIndex
Oct 22, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Oct 22, 202510-QQuarterly reportDocumentIndex
Oct 14, 20258-KMaterial eventDocumentIndex
Sep 9, 20258-KMaterial eventDocumentIndex
Aug 26, 2025N-PXDocumentIndex
Jul 24, 202510-QQuarterly reportDocumentIndex
Jul 22, 202513F-HRInstitutional holdings reportDocumentIndex
Jul 16, 20258-KMaterial eventDocumentIndex